Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins

Journal of Surgical Research

Volumn 66, Issue 2, 1996, Pages 174-178

  Galdbart, Jacques Olivier ^a   Branger, Catherine ^a   Andreassian, Bernard ^a   Lambert Zechovsky, Nicole ^a   Kitzis, Michel ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; COLLAGEN; DACRON; FUSIDIC ACID; GELATIN; GLYCOPEPTIDE; PEFLOXACIN; POLYETHYLENE; PRISTINAMYCIN; PROTEIN; RIFAMPICIN; SEALANT; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DACRON IMPLANT; DRUG HALF LIFE; DRUG RELEASE; PRIORITY JOURNAL;

EID: 0030505405     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0391     Document Type: Article

References (29)

1. 1. Bunt, T. J. Synthetic vascular graft infections. I. Graft infections. Surgery 93: 733, 1983.
2. 2. Cherry, K. J., Roland, C. F., Pairoler, O. P. C., Hallett, J. W., Meland, N. B., Naessens, J. M., Glovicski, P., and Bower, T. C. Infected femorodistal bypass: Is graft removal mandatory? J. Vasc. Surg. 15: 298, 1992.
3. 3. Liekweg, W. G., and Greenfield, L. J. Vascular prosthetic infections: Collected experience and results of treatment. Surgery 81: 335, 1977.
4. 4. Sheng, F. C., and Busuttil, R. W. Antibiotics in vascular surgery. In W. S. Moore (Ed.), Vascular Surgery: A Comprehensive Review. Philadelphia, PA: Saunders, 1991. Pp. 262-274.
5. 5. Lorentzen, J. E., Nielsen, O. M., and Arendrup, H. Vascular graft infection: An analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 98: 81, 1985.
6. 6. Goldstone, J., and Moore, W. S. Infection in vascular prostheses. Am. J. Surg. 128: 225, 1974.
7. 7. Buchbinder, D., Leather, R., Shah, D., and Karmody, A. Pathologie interactions between prosthetic aortic grafts and the gastrointestinal tract. Am. J. Surg. 140: 192, 1980.
8. 8. Moore, W. S., and Cole, C. W. Infection in prosthetic vascular grafts. In W. S. Moore (Ed.), Vascular Surgery: A Comprehensive Review. Philadelphia, PA: Saunders, 1991. Pp. 598-609.
9. 9. Bandyk, D. F., Berni, G. A., Thiele, B. L., and Towne, J. B. Aorto femoral graft infections due to Staphylococcus epidermidis. Arch. Surg. 119: 102, 1984.
10. 10. Schmitt, D. D., Bandyk, D. F., Pequet, A. J., Malangoni, M. A., and Towne, J. B. Mucin production by Staphylococcus epidermidis: A virulence factor promoting adherence to vascular grafts. Arch. Surg. 121: 89, 1986.
11. 11. Richardson, R. L., Pate, J. W., Wolf, R. Y., Ledes, C., and Hopson, W. B. The outcome of antibiotic soaked arterial grafts in guinea pig wounds contaminated with E. coli or S. aureus. J. Cardiovasc. Thorac. Surg. 59: 635, 1970.
12. 12. Kempzinski, R. F. Commentary to W. S. Moore. Development of an infection-resistant vascular prosthesis. Arch. Surg. 116: 1403, 1981.
13. 13. Prahlad, A., Harvey, R. A., and Greco, R. S. Diffusion of antibiotics from a polytetrafluoroethylene-benzalkonium surface. Am. J. Surg. 47: 515, 1981.
14. 14. Shenk, J. S., Ney, A. L., Tsukayama, D. T., Olson, M. E., and Bubrick, M. P. Tobramycin-adhesive in preventing and treating PTFE vascular graft infections. J. Surg. Res. 47: 487, 1989.
15. 15. Clark, R. E., and Morgraf, H. W. Antibacterial vascular grafts with improved thromboresistance. Arch. Surg. 109: 159, 1974.
16. 16. Chervu, A., Moore, W. S., Chvapil, M., and Henderson, T. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J. Vasc. Surg. 13: 897, 1991.
17. 17. Moore, W. S., Chvapil, M., Seiffert, G., and Keown, K. Development of an infection-resistant vascular prosthesis. Arch. Surg. 116: 1403, 1981.
18. 18. Powell, T. W., and Burnham, S. J. A passive system using rifampicin to create an infection-resistant vascular prosthesis. Surgery 94: 765, 1983.
19. 19. Chervu, A., Moore, W. S., Gelabert, H. A., Colburn, M. D., and Chvapil, M. Prevention of graft infection by use of prostheses bonded with a rifampin-collagen release system. J. Vasc. Surg. 14: 521, 1991.
20. 20. Goeau-Brissonniere, O., Leport, C., Bacourt, F., Lebrault, C., Comte, R., and Pechere, J. C. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed dacron graft. Ann. Vasc. Surg. 5: 408, 1991.
21. 21. Avramovic, J., and Fletcher, J. P. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin. J. Cardiovasc. Surg. 33: 70, 1992.
22. 22. Anhalt, J. P. Assays for antimicrobial agents in body fluids. In A. Ballows, W. J. Hausler, K. L. Hermann, H. D. Isenberg, and H. J. Shadomy (Eds.), Manual of Clinical Microbiology, 5th ed. Washington, DC: American Society for Microbiology, 1991. Pp. 1192-1198.
23. 23. Kitzis, M. Antibiophylaxie en chirurgie vasculaire. Ann. Fr. Anesth. Reanim. 13: 88, 1994.
24. 24. Ashton, T. R., Cunningham, J. D., Paton, D., and Maini, R. Antibiotic loading of vascular grafts. Proceedings, 16th Annual Meeting of the Society for Biomaterials, Charleston, South Carolina, May 20-23, 1990. P. 235.
25. 25. Hirt, S. W., Aoki, M., Demertzis, S., Siclari, F., Haverich, A., and Borst, H. G. Comparative in vivo study on the healing qualities of four different presealed vascular prostheses. J. Vasc. Surg. 17: 538, 1993.
26. 26. Berger, K., Sauvage, L. R., and Wood, S. J. Healing of arterial prostheses in man: Its incompleteness. Ann. Surg. 175: 118, 1972.
27. 27. Vohra, R., Thomson, G. J. L., Carr, H. M. H., Sharma, H., and Walker, M. G. Comparison of different vascular prostheses and matrices in relation to endothelial seeding. Br. J. Surg. 78: 417, 1991.
28. 28. Kitzis, M., Branger, C., and Andreassian, B. Vancomycin for surgical prophylaxis in recurrent vascular procedure. Proceedings, 41th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, September 30, 1991. [Abstract 929]
29. 29. Maki, D. G., Botin, M. J., and Stoltz, S. M. Comparative study of cefazolin, cefamandole and vancomycin per surgical prophylaxis in cardia and vascular surgery: A double blind randomized trial. J. Thorac. Cardiovasc. Surg. 104: 1423, 1992.